Dr. Saab is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000
Education & Training
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 2003 - 2007
- Duke University HospitalResidency, Pediatrics, 2000 - 2003
- American University of Beirut Faculty of MedicineClass of 1999
Certifications & Licensure
- CA State Medical License 2022 - 2026
- NC State Medical License 2000 - 2003
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease Start of enrollment: 2024 Mar 13
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 70 citationsPharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cellsRaya Saab, Jennifer L. Bills, Alexander P. Miceli, Colleen Anderson, Joseph D. Khoury
Molecular Cancer Therapeutics. 2006-05-01 - 3 citationsMolecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.Giselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, Jacqueline Kraveka, William Ferguson
Genome Medicine. 2024-02-12 - 4 citationsDevelopment of EPAT: An assessment tool for pediatric hematology/oncology training programs.Daniel C Moreira, Monika L Metzger, Federico Antillón-Klussmann, Oscar González-Ramella, Yijin Gao
Cancer. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: